# RN1201 Injection in the Treatment of Antibody-Mediated Diseases

> **NCT07072247** · PHASE1 · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 9 (estimated)

## Conditions studied

- Refractory Immune-mediated Platelet Transfusion Refractoriness
- Relapsed or Refractory Immune Thrombocytopenia

## Interventions

- **GENETIC:** CD19 and BCMA-targeted allogeneic CAR-T cells

## Key facts

- **NCT ID:** NCT07072247
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-10
- **Primary completion:** 2026-07-30
- **Final completion:** 2027-07-30
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2025-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07072247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07072247, "RN1201 Injection in the Treatment of Antibody-Mediated Diseases". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07072247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*